Shares of Aquestive Therapeutics Inc. (AQST) are up over 11% at $4.74 in premarket trading today, as the company gears up for reporting financial results for the fourth quarter ended December 31, 2023, tomorrow. The company has five commercialized products marketed by its licensees in the U.S. and around the world.For full year 2023, the company expects revenue to be in the range of $47 million t...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.